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INTRODUCTION 
Epilepsy a chronic disorder of heterogeneous symp-
toms characterized by recurrent seizures, seizures are 
finite episodes of brain dysfunction resulting from ab-
normal discharge of cerebral neurons.  The causes of 
seizures are extremely diverse and include the full 
range of neurological diseases from infections to neo-
plasm, head injury. Heredity has proved to be a pre-
dominant factor in some subgroups [1,2]. 
Approximately 1% of the world’s population has epilep-
sy, the second most common neurological disorder 
after stroke. The therapeutic objective of the treatment 
of epilepsy is complete seizure control without exces-
sive side effects.  Uncontrolled epilepsy can result in 
neuropsychiatric and social impairment, lower quality 
of life, greater morbidity and higher risk of death [1-3]. 
Several different classes of drugs are available for treat-
ment of the epilepsy.  They act by different mecha-
nisms, such as blockade of SRF(Sustained repetitive 
firing) by enhancing sodium channel inactivation, en-
hancing GABAnergic inhibition or by reducing T- calci-
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um currents, enhancing K+ current blockade of NMDA(N
-methyl-D-aspartate) receptors, blockade of AMPA 
(aminomethylphosphonic acid) receptors and blockade 
of Kainic acid receptors [3].  These drugs have limita-
tions mainly due to their toxicity profile and drug-drug 
interactions. In addition, epilepsy remains resistant to 
drug therapy in about one third of patients, thus en-
couraging the development of drugs that act on mecha-
nisms underlying pharmacoresistance. 
The role of inflammation and immune mediated insults 
in seizure initiation and process of epileptogenesis has 
been supported by many studies [4, 5]. Experimental 
studies in animals have proved that neuroinflammation 
can lead increase in permeability of blood brain barrier 
and excitability of nervous tissue [6,7]. 
Role of oxidative stress in epileptogenesis process has 
been supported in various experimental studies [8]. 
Mitochondrial related oxidative stress plays an im-
portant role in the epileptogenesis in lithium- pilocar-
pine model of temporal lobe epilepsy in animals [9].  
Anti-oxidants can reduce the severity of neuronal injury 
caused by oxidative stress and therefore development 
of seizures in some animal models [10]. 
Clinically used calcium channel blockers act by blocking 
L-type and T-type of calcium channels which are present 
in various tissues including brain and they are common-
ly prescribed for treatment of various clinical conditions 
such as hypertension, angina and cardiac arrhythmias 
[11].  In various experimental animal models, calcium 
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channel blockers have been shown to exhibit the anti-
inflammatory and antioxidant properties [12]. In addi-
tion calcium channel blockers have several advantages 
over the existing anti-epileptic drugs, such as no effect 
on hepatic microsomal enzymes, devoid of sedation, 
interference with quality of life and wide therapeutic 
range.  They are even best suited for elderly individu-
als. 
The present study is therefore undertaken to evaluate 
the antiepileptic effect of clinically used calcium chan-
nel blockers and also to evaluate their ability to poten-
tiate the antiepileptic effect of existing drugs. 
Objectives:  
1. To evaluate the antiepileptic potential of CCBs, 
phenytoin and comparison with phenytoin.  
2. To evaluate the ability of the CCBs to potentiate 
the anti-epileptic effect of phenytoin.   
 
MATERIALS AND METHODS  
 
Study design: Randomized, an experimental study 
Ethics approval: The study was approved by institution-
al ethics committee 
Study locus and period: Study was conducted in de-
partment of Pharmacology, Shri B M Patil Medical Col-
lege, Bijapur 
Animals:   Inbred, 36 male wistar rats, weighing 150-
200g were selected for the present study.  
Maximum electric shock method (MES induced epilep-
sy): The above animals were subjected to electroshock 
of 150 mA intensity for 0.2 seconds through auricular 
electrodes, [covered in cotton wool & saline mois-
tened) [12]. 
Inclusion criteria: A majority of  rats showed tonic flex-
ion of  fore & hind limbs with tail erection, tonic exten-
sion of  both fore & hind limbs, clonus, stupor followed 
by post ictal depression & recovery. Only those rats 
showing the convulsive responses were used for exper-
iment. 
Grouping of animals: Rats were divided into 6 groups 
and in each group n=6 
Group 1: Vehicle control (MES with our any treatment) 
Group 2: MES and treated with standard drug 
(phenytoin 25mg/kg)  
Group 3: MES and treated with Nifedipine (5mg/kg)  
Group 4: MES and treated with Verapamil (20mg/kg) 
Group 5: MES and treated Nifedipine (2.5mg/kg) + 
phenytoin (12.5mg/kg)  
Group 6: MES and treated Verapamil (10mg/kg) + 
phenytoin (12.5mg/kg)  
The above doses were selected from the pilot study 
and the combination were taken half of the doses as 
assuming to produces potentiation effect.  
Parameters studied:  
1. Presence or absence of Tonic Hind Limb Extension 
(THLE) in rats. 
2. Duration of tonic extension. 
No animals were sacrificed in the study.  Animals were 
rehabilitated according to CPCSEA guidelines. 
Statistical analysis: All the values were expressed as 
the mean ± SEM and (p<0.05). The latency to convulse 
and duration of HLE were analysed by one way analysis 
of variance (ANOVA). For comparison between multiple 
groups, one way ANOVA followed by post hoc Tukey’s 
test was performed. Analysis of the seizure protection 
and percentage mortality was done by Fisher’s exact 
test. The “p” value of <0.05 was considered as statisti-
cally significant .  
 
RESULTS  
 
In Maximal Electroshock (MES) Method the parameters 
like the latency to convulse, duration of tonic convul-
sion (hind limb tonic extension i.e HLE), the percentage 
seizure protection and the percentage mortality were 
recorded and results obtained in different groups rep-
resented in figures. As seen in Figure 1, Phenytoin 
group (Group II) shown complete abolition of convul-
sion, highly statistically significant decrease in duration 
of tonic hind limb extension, increase in seizure protec-
tion (83.33%) and any percentage mortality compared 
to control group (p < 0.05). 
In only calcium channel blockers (Nifedipine and Vera-
pamil) groups, Nifedipine group (Group III) and Vera-
pamil group (Group IV) shown statistically non signifi-
cant increase in latency to convulse and decrease in 
duration of tonic hind limb extension phase (Figure 3)
when compared to control group (p < 0.05). Whereas, 
in both these group statistically non significant in-
creased percentage epilepsy protection (Figure 2) and 
decreased percentage mortality was found when com-
pared with control group (Group I). 
Vijayalaxmi Uppin et al.,   Antiepileptic Effect of Calcium Channel Blockers Alone and in Combination with Phenytoin on MES Induced Epilepsy in Rats. 
Figure 1. Latency to convulsions of experimental 
groups in MES method 
Figure 2. Duration of Hand limb extension (in sec) 
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Phenytoin and calcium channel blockers (Nifedipine 
and Verapamil) combination groups (Group V and VI) 
depicts statistically significant increase in latency to 
convulse and decrease in duration of HLE when com-
pared to control group. In both these group statistically 
significant increased percentage epilepsy protection 
and decrease in percentage mortality was noted when 
compared to control group (Group I) (p < 0.05). 
 
DISCUSSION 
 
In our study finding showed, in only Nifedipine group 
(Group III) and Verapamil group (Group IV) have shown 
statistically non significant increase in latency to con-
vulsion and decrease in duration of HLE when com-
pared to control group (Group I). Whereas, in both 
these group statistically non significant increased per-
centage epilepsy protection  and decreased percentage 
mortality was found when compared with control 
group (Group I). Two out of six animals were protected 
against MES induced seizures in all the phases with 
Nifedipine and only one out of six animals was protect-
ed against MES induced seizures in all the phases with 
Verapamil. Whereas, Sodium valproate and calcium 
channel blockers (Nifedipine and Verapamil) combina-
tion groups (Group V and VI) results depicts statistically 
significant increase in latency to convulsions and de-
crease in duration of clonic convulsions when com-
pared to control group (Group I) (p < 0.05). In both 
these group statistically significant increased percent-
age epilepsy protection and decrease in percentage 
mortality was noted when compared to control group 
(Group I). Five out of six animals were protected 
against MES induced seizures in all the phases with 
Nifedipine and similarly four out of six animals were 
protected against MES induced seizures in all the phas-
es with Verapamil. Further, when we observed both 
these calcium channel blockers (Nifedipine and Vera-
pamil) combination groups with Phenytoin and stand-
ard control group (Group II) treated with only Phenyto-
in showed almost same potential antiepileptic results 
on experimental animals.  
Hadizadeh F et al [13] studied anticonvulsant activity of 
two novel 4 (1- (4-flurobenzyl)-5 imidazolyl) dihydro-
pyridine derivatives in mice using pentenylenetetrazole 
and electroshock seizure models. Sodium valproate, 
phenytoin sodium and nifedipine were used as positive 
controls.  The above study demonstrated that the two 
dihydropyridine derivatives have significant anticonvul-
sant activity in both the animal experimental models. 
Patten S R et al [14] evaluated new substituted dihydro-
pyridine derivatives for their anticonvulsant activity in 
rats using Pentylenetetrazole, Strychnine and Maximum 
Electroshock models.  His study confirmed significant 
anticonvulsant properties of these compounds. 
Shafiee  A et al [15] studied anticonvulsant activities of 
alkyl’ arylalkyl and cycloalkyl ester analogues of nifedi-
pine in pentylenetetrazole induced seizures in mice at 
Department of Medicinal Chemistry and Toxicology, Teh-
ran University, Tehran.  The study confirmed that all the 
above analogues of nifedipine had significant effect in 
reducing the latency and duration of seizures. 
A study carried out by Umukoro S et al [16] to evaluate 
the anticonvulsant activity of two Calcium channel block-
ers, Verapamil and Nifedipine in Swiss albino mice.  In 
this study, strychnine was administered intraperitonealy 
in the dose of 1mg/kg to induce convulsions.  Both the 
calcium channel blockers prolonged the onset of seizures, 
when compared to controls (p<0.05). 
Study done at university of Reggio Calabria [17], Italy 
showed that calcium channel blockers like flunarizine, 
nifedipine, nicardipine, nimodipine, nitrendipine and dil-
tiazem exhibited significant anticonvulsant activity in 
DBA/2 mice.  In this study the convulsions were induced 
in experimental animals by auditory stimulation (109 db).  
However, veapamil did not exhibit anticonvulsant activity 
in this study.  
Sathyanarayan Rao K et al [18] carried out study to evalu-
ate anticonvulsant activity of Amlodipine in mice using 
MES and PTZ models. Sodium valproate and normal sa-
line were used as standard and control respectively. This 
study indicated that Amlodipine may be considered as 
addon therapy for epilepsy. 
Shitak R et al [19] carried out a study to evaluate anti-
seizure efficacy of Nimodipine in pentylenetetrazole and 
kainic acid combined seizure models in mice. Nimodipine 
(5mg/kg, ip) significantly protected mice from convul-
sions in both of the combination in vivo seizure models. 
Brahmane et al [20] evaluated anti-convulsant activity of 
cinnarazine and nifedipine in mice using maximal electro-
shock and pentylenetetrazole models and showed that 
both the calcium channel blockers had significant anti- 
convulsant activity as compared to controls.  It was also 
observed that both the calcium channel blockers signifi-
cantly potentiated the effect of sodium valproate in both 
the models.  
 
CONCLUSION  
 
Verapamil and nifedipine produced significant antiepi-
leptic effect alone. Verapamil and nifedipine potentiat-
ed the antiepileptic effect of phenytoin sodium. Dose of 
phenytoin sodium can be reduced in epileptic patients 
receiving verapamil or nifedipine for some other clinical 
Figure 3. Percentage epilepsy protection of experi-
mental groups in MES method 
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conditions. Verapamil and nifedipine can also be used 
alone in the treatment of generalized tonic-clonic sei-
zures. However, it needs further confirmation to es-
tablish clinical utility of calcium channel blockers.  
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